Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia

Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia

The purpose of the study is to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the All-Russian Scientific Cardiology Society guidelines/ the 4th Joint European Task Force guidelines.

Inclusion Criteria:

• Subject must be 18 years of age or older of either gender or race.
• Subject must provide informed consent and comply with the survey procedures.
• Subject is on lipid lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks.

Exclusion Criteria:

• Subjects who are unwilling or unable to provide informed consent